KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBITDA Margin (2016 - 2025)

Johnson & Johnson's EBITDA Margin history spans 17 years, with the latest figure at 81.68% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 265.0% year-over-year to 81.68%; the TTM value through Dec 2025 reached 42.39%, up 140.0%, while the annual FY2025 figure was 42.39%, 140.0% up from the prior year.
  • EBITDA Margin for Q4 2025 was 81.68% at Johnson & Johnson, up from 29.31% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 87.19% in Q1 2023 and bottomed at 18.3% in Q1 2021.
  • The 5-year median for EBITDA Margin is 28.56% (2021), against an average of 40.61%.
  • The largest annual shift saw EBITDA Margin skyrocketed 2307bps in 2022 before it plummeted -2061bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 28.31% in 2021, then skyrocketed by 82bps to 51.38% in 2022, then surged by 62bps to 83.49% in 2023, then grew by 1bps to 84.33% in 2024, then dropped by -3bps to 81.68% in 2025.
  • Per Business Quant, the three most recent readings for JNJ's EBITDA Margin are 81.68% (Q4 2025), 29.31% (Q3 2025), and 27.99% (Q2 2025).